or Try an Advanced Search...

    Technical Analysis for MYNZ - Mainz Biomed B.V.

    Grade Last Price % Change Price Change
    F 0.68 5.90% 0.04
    MYNZ closed up 5.9 percent on Friday, May 17, 2024, on 71 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    Earnings due: May 31
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Flat
    Historical MYNZ trend table...
    Date Alert Name Type % Chg
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
    Wide Bands Range Expansion 0.00%
    Up 3 Days in a Row Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    Pocket Pivot Bullish Swing Setup 5.90%
    Outside Day Range Expansion 5.90%
    Wide Bands Range Expansion 5.90%
    Oversold Stochastic Weakness 5.90%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 6.57%
    Pocket Pivot Bullish Swing Setup 6.57%
    Older End-of-Day Signals for MYNZ ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance 1 day ago
    Up 10% 1 day ago
    Rose Above Previous Day's High 1 day ago
    Rose Above 10 DMA 1 day ago
    60 Minute Opening Range Breakout 1 day ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    MYNZ Chart by TradingView
    Basic chart:

    Profile

    Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic tests for clinical diagnostics in the area of human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, an early-stage molecular lateral-flow test; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Cancer Clinical Medicine Medical Genetics Colorectal Cancer Pancreatic Cancer Medical Test Diagnostic Tests Molecular Diagnostics Cancer Screening Innogenetics

    Is MYNZ a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 16 Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
    May 7 Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.
    Apr 29 mRNA Is Promising A Breakthrough In Fighting Cancer
    Apr 25 Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic
    Apr 10 The Pharmaceutical Industry Finds Itself At A Historical Crossroads
    Apr 9 Mainz Biomed Reports Full Year 2023 Financial Results
    Apr 2 Pharma's Post-Pandemic Story To Unlock A Cancer-Free Era
    Mar 19 Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment
    Mar 18 Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options
    Mar 12 Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations
    See more MYNZ news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 6.0
    52 Week Low 0.6
    Average Volume 117,607
    200-Day Moving Average 1.70
    50-Day Moving Average 0.92
    20-Day Moving Average 0.76
    10-Day Moving Average 0.68
    Average True Range 0.08
    RSI (14) 37.11
    ADX 25.77
    +DI 14.91
    -DI 21.55
    Chandelier Exit (Long, 3 ATRs) 0.84
    Chandelier Exit (Short, 3 ATRs) 0.84
    Upper Bollinger Bands 0.94
    Lower Bollinger Band 0.57
    Percent B (%b) 0.29
    BandWidth 48.13
    MACD Line -0.08
    MACD Signal Line -0.08
    MACD Histogram -0.0038
    Fundamentals Value
    Market Cap 13.84 Million
    Num Shares 20.4 Million
    EPS -1.92
    Price-to-Earnings (P/E) Ratio -0.35
    Price-to-Sales 24.92
    Price-to-Book 6.79
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.81
    Resistance 3 (R3) 0.81 0.76 0.79
    Resistance 2 (R2) 0.76 0.73 0.76 0.78
    Resistance 1 (R1) 0.72 0.70 0.74 0.72 0.78
    Pivot Point 0.67 0.67 0.68 0.67 0.67
    Support 1 (S1) 0.63 0.64 0.65 0.63 0.58
    Support 2 (S2) 0.58 0.61 0.58 0.57
    Support 3 (S3) 0.54 0.58 0.57
    Support 4 (S4) 0.54